Search for:

The Health Pod, Baker McKenzie’s industry podcast series, highlights sector-specific issues and trends that affect healthcare and life sciences companies.

Episode 1: Health Canada and the FDA’s Response to COVID-19

Resolving the health crisis demands an immediate response from regulatory agencies. In this episode of The Health Pod, Kamleh Nicola and Veleka Peeples-Dyer join David Wardell in discussing some of the most significant responses by Health Canada and the FDA to COVID-19.

 

 

Episode 2: COVID-19 Impact on Biopharma Clinical Development in the EU and Mexico

The disruptive impact of COVID-19 has forced the healthcare and life sciences industries to adapt in different ways. In this episode of The Health Pod, Els Janssens and Christian Lopez-Silva join David Wardell in discussing the effect COVID-19 has had on the management of clinical trials in the EU and Mexico and how the regulators have dealt with these impacts.

 

 

Episode 3: Alternative Arrangements for Biopharma Clinical Funding

The lengthy, expensive and complex nature of drug development has brought about the emergence of alternative funding entities to help boost R&D productivity, lower costs and mitigate risks. In this episode of The Health Pod, Randall Sunberg joins David Wardell in discussing how these investment companies are bridging the funding gap, and the types of agreements and due diligence involved in these arrangements.

 

Author

David Wardell has been practicing law since 1982, mainly in the area of international corporate and commercial law. He serves on the steering committee of both the Global Healthcare Industry Group and the North America Healthcare Industry Group. He is also the Chicago office representative of the Firm’s French Initiative. Prior to joining the Firm, Mr. Wardell practiced for over 26 years first as an Assistant District Attorney in Manhattan under Robert Morgenthau and then at Bristol-Myers Squibb Company, Abbott Laboratories and Tenneco Inc., where he served as general counsel and chief compliance officer.

Author

Dianne Phoebus is member of the steering committees of the Firm’s Intellectual Property Practice Group and Pharmaceuticals & Healthcare Industry Group in Latin America. She practices mainly in the areas of intellectual property and health law, and is ranked among the leading intellectual property lawyers in Venezuela by Chambers Latin America and World Trademark Review. Ms. Phoebus is also an active member of the International Trademark Association and the Intellectual Property Committee of the Venezuelan-American Chamber of Commerce. She teaches legal English at the Universidad Monteávila.